Search

Die Insolvenzstatistik ist seit Beginn der Corona-Pandemie noch stärker in den öffentlichen Fokus gerückt. Seit Mai 2020 veröffentlicht das Statistische Bundesamt einen Frühindikator, der die amtlichen Ergebnisse der Insolvenzstatistik ergänzt. Dadurch ist es möglich, Entwicklungen im bundesweiten Insolvenzgeschehen zwei Monate früher als zuvor zu identifizieren. Für den Frühindikator verwendet das Statistische Bundesamt die Angaben einer öffentlichen Internetseite zu Insolvenzbekanntmachungen, eine bisher ungenutzte Datenquelle. Der Aufsatz beschreibt die Entwicklung sowie die ersten Ergebnisse des Frühindikators und analysiert das aktuelle Insolvenzgeschehen in Deutschland. Since the beginning of the coronavirus pandemic, insolvency statistics have increasingly become a focus of public attention. Since May 2020, the Federal Statistical Office has published a flash indicator to supplement the results of the official insolvency statistics. This enables trends in the total insolvency figures for Germany to be identified two months earlier than before. The Federal Statistical Office uses a new data source, namely a public website with insolvency announcements, for compiling the flash indicator. This article describes the development and first results of the flash indicator, and it analyses the current insolvency situation in Germany.

Aims: Depressive symptoms in children and adolescents are commonly treated with serotonin re-uptake inhibitors like fluoxetine. Astrocytes expressing different serotonin receptors (5-HTRs) and the serotonin transporter (5-HTT) are affected by fluoxetine administration. The study was conducted to revise whether fluoxetine treatment during postnatal brain development results in long-term changes of astroglia. Methodology: Thus, immunohistochemistry and real-time PCR analyses were performed at different postnatal periods in rats to investigate short- and long-term changes following by a 14-day administration with fluoxetine (5 mg/kg/BW s.c. once daily). Results: Fluoxetine-treatments from postnatal day (pd) 1-15, measured at pd 16, led to a significant reduction of GFAP gene (Gfap) in hippocampus and GFAP protein expression in the dentate gyrus and CA1 without changes at pd 90 compared to controls. Treatments from pd 21-35 resulted in a significant decrease of Gfap and protein (measured 24 hours after last injection) in striatum (putamen), frontal cortex and hippocampus. Contrary, if measured at day 90, the same treatment led to a significant increase in those regions. Later treatments from pd 50-64 did not result in significant changes in mRNA or in protein expression. Conclusion: This study revealed a fluoxetine-sensitive period of brain astrocyte development (i.e. periadolescence) that led to structural effects, which can even be detected in adulthood. These results might be relevant for psychopharmacological treatment in children and require continuative clinical studies.